The $124 Trillion Shift
What the Great Wealth Transfer Actually means for Private Capital
There is a shift underway in private capital that does not yet have a consensus name, a standard framework, or an established playbook. It is, however, already measurable and its implications extend well beyond the client demographic discussions it is most commonly reduced to.
$124 trillion is transferring between generations over the next two decades. Women will receive a disproportionate share of it. According to the Bank of America Institute, roughly $54 trillion will pass to surviving spouses of whom 95% are women. A further $47 trillion will be inherited by women in younger generations. By 2030, women are projected to control $34 trillion in investable assets; three times the quantity they held at the start of this decade1.
These are not social statistics. They are capital flow data. And they carry implications for how private wealth must be structured, advised, and stewarded that the industry is only beginning to work through.
What changes when capital changes hands
The Great Wealth Transfer is sometimes discussed as though the primary question is how to retain assets under management during a period of generational transition. That framing, while understandable, may be the wrong one.
The more consequential question is not whether capital stays with the same institution. It is whether the institution understands how the new stewards of that capital think about it; what they want it to do, over what time horizon, and through what kinds of decisions.
The evidence here is consistent and worth taking seriously. Women tend to invest with longer time horizons. They trade less frequently, maintain more diversified portfolios, and demonstrate stronger conviction around values-aligned categories. Fidelity’s analysis of 5.2 million accounts over ten years found women achieved returns 0.4% higher than men annually; a difference that compounds materially over the multi-decade horizons relevant to private wealth.
More significantly for wealth managers: women increasingly view capital not as a performance instrument alone, but as a medium for expressing long-term conviction.
Research from UBS, Morgan Stanley, and Fidelity consistently shows that women are significantly more likely than men to align investments with ESG factors, and to define wealth in terms of financial security, life flexibility, and long-term purpose rather than accumulation2.
These preferences are not peripheral to portfolio construction. They are the parameters within which the next generation of wealth management relationships will be built.
Where the signal is clearest
Women’s wealth does not only reveal a shift in who holds capital. It reveals a shift in what capital must do.
As I wrote in an earlier piece, women’s experience with capital tends to surface certain dynamics earlier because women disproportionately encounter the life-stage transitions that expose where existing frameworks strain. Longevity risk. Healthcare costs. Caregiving interruptions. Intergenerational responsibility. These are not edge cases in private wealth management. They are, increasingly, the central cases.
And they require a different kind of capital stewardship; one designed not for market cycle optimisation alone, but for the full duration of a life that may span decades beyond the traditional investment horizon.
This is why the Great Wealth Transfer is not simply a demographic event. It is a recalibration of what private wealth management is for.
The investment implication hiding in plain sight
There is a category that sits at the precise intersection of these two shifts - the transfer of capital to women and the reorientation of how that capital is deployed.
Women’s health.
For decades, women’s health has been one of the most persistent market inefficiencies in healthcare. Despite representing half the global population, women’s health has been systematically under-researched, under-measured, and undercapitalised.
According to the World Economic Forum’s 2026 Women’s Health Investment Outlook, women’s health captures only 6% of private healthcare investment. Conditions affecting hundreds of millions of women globally (endometriosis, menopause, polycystic ovary syndrome) receive under 2% of private healthcare funding.
That is not a medical observation. It is a mispricing. And the women now receiving $124 trillion in transferred capital are the same women who have lived inside that mispricing and who, as allocators, are already beginning to direct capital toward correcting it.
The alignment between personal conviction and financial return in this category is unusually strong. The market formation is early. The institutional interest is growing; Blackstone’s acquisition of Hologic, a major women’s health diagnostics company, signalled to mainstream investors that this is a category with genuine institutional-grade opportunity.
The investors and institutions building relationships with this category now, developing the frameworks, the networks, and the portfolio exposure will be positioned for what follows as $34 trillion in female-controlled investable assets continues to grow.
A shift in stewardship
Private wealth management was developed for a set of conditions that are changing. Capital is being stewarded over longer horizons, through more complex life transitions, and by people who bring different questions to the table; questions about longevity, health, governance, and intergenerational purpose.
Women’s wealth is where these questions are most visible. But the shift they represent is broader.
The institutions that recognise this earliest will not simply retain assets under management through a period of generational transition. They will build the relationships, the frameworks, and the trust that define how private capital is stewarded for the next generation.
The Great Wealth Transfer is already underway. The question is not whether to respond to it. It is how quickly the response can move from recognition to redesign.
This is the first in a four-part series examining the intersection of the Great Wealth Transfer, women as capital allocators, and the emerging investment opportunity in women’s health.
Next: Women Don’t Invest Like the Models Assume And That’s Reshaping Long-Term Capital
Disclaimer
The content in this newsletter is for informational purposes only and does not constitute financial, investment, legal, or medical advice. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.
https://institute.bankofamerica.com/content/dam/economic-insights/women-and-wealth-creating-opportunities.pdf
This was a brilliant breakdown of the systemic barriers in women’s health investment. The connection between reimbursement gaps, policy stagnation, and downstream investor hesitancy is spot on.
I also love the point about tech-driven cost reductions shifting the economics of care.
Given these challenges, how can startups and women’s health advocates actively push for change?
Beyond building great products, what strategies can help drive improvements in systemic bias—whether through policy, investor education, or new funding models?”
This is an interesting article. At the beginning, you point to a study and refer to a broken pricing failure. In my opinion, it stems from the fact that there is a gender pay gap throughout the world. We all know about it and have talked about it, but seldom is something done actively to only pay for the work/service and not who renders it. It is as if no one has touched on this topic (sarcasm!) I am attempting to do so with my article "Global Gender Pay Gap" and hope to reach out to someone who can make a change to this issue.